Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of $749.200 million which beat the analyst consensus estimate of $714.893 million by 4.80 percent. This is a 62.05 percent increase over sales of $462.331 million the same period last year.